Sunshine Biopharma, Inc.
6500 Trans-Canada Highway
4th Floor
Pointe-Claire, Quebec, Canada H9R 0A5
May 18, 2022
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
| Re: | Sunshine Biopharma, Inc. | |
| Registration Statement on Form S-3 | ||
| Filed May 10, 2022 | ||
| File No. 333- 264830 |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Sunshine Biopharma, Inc. hereby respectfully requests acceleration of the effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 4:30 p.m. Eastern Time, May 20, 2022, or as soon as practicable thereafter.
| Very truly yours, | |
| Sunshine Biopharma, Inc. | |
| By: /s/ Dr. Steve N. Slilaty | |
| Dr. Steve N. Slilaty | |
| Chief Executive Officer |